SARS-CoV-2 Study Forecasts Emergence of Immune Escape Variants
SARS-CoV-2 study forecasts future variants’ ability to evade immune defenses and portends emergence of escape variants.
SARS-CoV-2 study forecasts future variants’ ability to evade immune defenses and portends emergence of escape variants.
Afghanistan Albania Algeria Andorra Angola Antigua and Barbuda Argentina Armenia Australia Austria Azerbaijan Bahamas Bahrain Bangladesh Barbados Belarus Belgium Belize Benin Bhutan Bolivia Bosnia and…
Individuals with diseases like diabetes, or those of advanced ages have reduced production of CGRP, leading to poor wound healing.
Canadian scientists have identified genes that may be partially responsible for the development of cerebral palsy.
Determining activity of the mitotic stopwatch in individual cancer might help predict tumor response to treatment with anti-mitotic drugs, researchers suggest
An AI method offers a new way to understand protein structures in multiple dimensions and may be a useful tool for pharmacology.
The study showed that DNA damage in response to stimuli triggers an inflammation pathway that prompts activity in memory-encoding neurons.
Lonza’s new offering provides manufacturing of spray-dried protein formulations, nucleotide-based drugs, and peptides.
Depleting myeloid-biased HSCs in aged mice restored features of a more youthful immune system, while reducing age-related markers of immune decline
Synthego announced that it will focus solely on the therapeutic applications of CRISPR while spinning off a new company, EditCo Bio, which is positioned to…
Phase I/IIa data for a single dose of REGENEXBIO’s gene therapy, RGX-314, shows promise for treating wet age-related macular degeneration.